Hong-Hong Yan

Guangdong Academy of Medical Sciences

Daxuecheng Outer Ring E Rd,

Panyu Qu

Guangzhou Shi, Guangdong Sheng

China

SCHOLARLY PAPERS

2

DOWNLOADS

34

SSRN CITATIONS

0

CROSSREF CITATIONS

2

Scholarly Papers (2)

The Resistance Landscape of Abivertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, and Clinical Strategy to Overcome Resistance in EGFR T790M-Positive Non-Small Cell Lung Cancer

Number of pages: 37 Posted: 28 Jan 2019
Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Burning Rock Biotech, Burning Rock Biotech, Burning Rock Biotech, Burning Rock Biotech, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, ACEA Therapeutics Inc., ACEA Therapeutics Inc., ACEA Therapeutics Inc., Guangdong Academy of Medical Sciences, Guangdong General Hospital, Guangdong Lung Cancer Institute, Department of Pulmonary Oncology and Guangdong Academy of Medical Sciences
Downloads 14 (584,755)

Abstract:

Loading...

Abivertinib, resistance, EGFR amplification

The Resistance Landscape of Abivertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, and Clinical Strategy to Overcome Resistance in EGFR T790M-Positive Non-Small Cell Lung Cancer

Number of pages: 38 Posted: 01 Mar 2019
Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Burning Rock Biotech, Burning Rock Biotech, Burning Rock Biotech, Burning Rock Biotech, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, ACEA Therapeutics Inc., ACEA Therapeutics Inc., ACEA Therapeutics Inc., Guangdong Academy of Medical Sciences, Guangdong General Hospital, Guangdong Lung Cancer Institute, Department of Pulmonary Oncology and Guangdong Academy of Medical Sciences
Downloads 6 (641,258)

Abstract:

Loading...

EGFR; T790M; abivertinib; resistance; NSCLC

2.

Development and Validation of a Gene Mutation-Based Signature to Predict Response to PD-1 Inhibitors in Non-Squamous NSCLC: A Retrospective Multicohort Study

Number of pages: 38 Posted: 12 May 2019
Southern Medical University - Department of Radiation Oncology, Southern Medical University - Department of Radiation Oncology, Southern Medical University - Department of Radiation Oncology, Southern Medical University - Department of Radiation Oncology, Southern Medical University - Department of Radiation Oncology, Southern Medical University - Hepatology Unit, Saint Louis University - College for Public Health and Social Justice, Southern Medical University - Department of Radiation Oncology, Southern Medical University - Department of Radiation Oncology, Southern Medical University - Department of Radiation Oncology, Southern Medical University - Department of Radiation Oncology, Southern Medical University - Hepatology Unit, Southern Medical University - Department of Radiation Oncology, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong General Hospital, Guangdong Lung Cancer Institute, Department of Pulmonary Oncology and Southern Medical University - Department of Radiation Oncology
Downloads 14 (562,503)

Abstract:

Loading...

gene mutation-based signature (GMS); non-squamous non-small cell lung cancer; PD-1/PD-L1; predictive; immunotherapy